全癌单细胞剖析揭示了表型上不同的B细胞亚型
Yu Yang1, Xueyan Chen1, Jieying Pan2
1Biomedical Pioneering Innovation Center (BIOPIC), Academy for Advanced Interdisciplinary Studies, and School of Life Sciences, Peking University, Beijing 100871, China.
Cell
|July 24, 2024
概括
这项研究揭示了各种瘤透性B细胞 (TIBs),确定了新的预后子集,如预测免疫治疗反应的瘤相关异常B细胞 (TAABs).
科学领域:
- 免疫学
- 癌症学
- 生物信息学
背景情况:
- 瘤透B细胞 (TIBs) 在癌症发展中起着复杂的作用.
- 了解TIB异质性对于癌症研究和治疗至关重要.
研究的目的:
- 创建来自不同癌症类型的人类B细胞的综合资源.
- 描述TIB异质性,并确定新的瘤丰富亚群.
- 评估已识别的TIB子集的预后和预测潜力.
主要方法:
- 整合了649名癌症患者的单细胞RNA测序数据.
- 对B细胞丰度,亚型组成和同型分布的分析.
- 用瘤丰富的B细胞亚群的鉴定和表征.
主要成果:
- 在19种癌症类型中观察到TIB丰度和组成的实质性异质性.
- 在分泌抗体细胞同型中观察到免疫球蛋白G (IgG) 的偏差.
- 确定了两种新的瘤丰富亚群,即应激反应记忆B细胞和与瘤相关的非典型B细胞 (TAAB).
- TAAB 具有高克隆扩张,增殖能力和与 CD4 T 细胞的相互作用,预测免疫治疗反应.
结论:
- 这项研究为了解癌症中的B细胞多样性提供了宝贵的资源.
- 确定的TIB子集,特别是TAAB,具有显著的预后和预测价值.
- 这些发现为进一步探索瘤学中的B细胞功能奠定了基础.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...